Michael Thomas

Mike Thomas provides fractional CEO services for several medical technology, digital health, and medical device startups. He also is a Senior Commercialization Advisor for DARPA and NobleReach Foundation for the Embedded Entrepreneur Initiative (EEI). He has managed a portfolio of over a dozen DARPA-funded performers and, at the request of the Office of Science and Technology Policy, was a founding architect of the Advanced Research Projects Agency for Health (ARPA-H).

Mike was a VC at the Inova Health System Strategic Investments (ISI) in northern VA. Prior to that, he was a serial healthcare technology CEO for over 20 years. Mike raised $125 million in capital and drove shareholder returns that ranged from 4x to 80x, including one IPO and one acquisition. Previously, Mike was CEO of iSonea Ltd (ASX:ISN), a publicly traded global mobile health app developer and medical device manufacturer in the respiratory disease market, where he increased the company’s market capitalization from $4 million to $250 million. He is a former board member of AdvaMed, the global medical device association.

Mike was most recently the founder and CEO of Appian Medical, a digital health firm that served the sleep apnea market, and is currently a member of the Board of Directors for Tanzen Medical, Inc.